1. Home
  2. HUBC vs CING Comparison

HUBC vs CING Comparison

Compare HUBC & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUBC
  • CING
  • Stock Information
  • Founded
  • HUBC 2017
  • CING 2012
  • Country
  • HUBC Israel
  • CING United States
  • Employees
  • HUBC N/A
  • CING N/A
  • Industry
  • HUBC
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUBC
  • CING Health Care
  • Exchange
  • HUBC Nasdaq
  • CING Nasdaq
  • Market Cap
  • HUBC 19.3M
  • CING 17.3M
  • IPO Year
  • HUBC N/A
  • CING 2021
  • Fundamental
  • Price
  • HUBC $2.77
  • CING $4.73
  • Analyst Decision
  • HUBC
  • CING Strong Buy
  • Analyst Count
  • HUBC 0
  • CING 4
  • Target Price
  • HUBC N/A
  • CING $30.67
  • AVG Volume (30 Days)
  • HUBC 2.0M
  • CING 92.7K
  • Earning Date
  • HUBC 05-01-2025
  • CING 08-12-2025
  • Dividend Yield
  • HUBC N/A
  • CING N/A
  • EPS Growth
  • HUBC N/A
  • CING N/A
  • EPS
  • HUBC N/A
  • CING N/A
  • Revenue
  • HUBC $29,562,000.00
  • CING N/A
  • Revenue This Year
  • HUBC N/A
  • CING N/A
  • Revenue Next Year
  • HUBC N/A
  • CING N/A
  • P/E Ratio
  • HUBC N/A
  • CING N/A
  • Revenue Growth
  • HUBC N/A
  • CING N/A
  • 52 Week Low
  • HUBC $1.72
  • CING $1.80
  • 52 Week High
  • HUBC $14.00
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • HUBC 70.56
  • CING 63.10
  • Support Level
  • HUBC $1.98
  • CING $4.25
  • Resistance Level
  • HUBC $2.18
  • CING $4.69
  • Average True Range (ATR)
  • HUBC 0.22
  • CING 0.23
  • MACD
  • HUBC 0.11
  • CING 0.03
  • Stochastic Oscillator
  • HUBC 74.64
  • CING 93.25

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: